Your session is about to expire
← Back to Search
Local Anesthetic
Intercostal nerve block and wound infiltration with bupivacaine/epinephrine + dexamethasone for Robotic Lung Surgery
Phase 4
Waitlist Available
Research Sponsored by The Cooper Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
undergoing robotic wedge resection or lobectomy for lung mass(es)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours post-surgery
Awards & highlights
Study Summary
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 hours post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours post-surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Visual Analogue Scale pain scores
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Bupivacaine/epinephrine + dexamethasoneExperimental Treatment1 Intervention
Group II: Liposomal bupivacaineActive Control1 Intervention
Find a Location
Who is running the clinical trial?
The Cooper Health SystemLead Sponsor
75 Previous Clinical Trials
24,079 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger